Evidence map›Paper›PMID 23580590›Full record

ReviewEndocrine-related cancer2013

Current mouse and cell models in prostate cancer research.

Xinyu Wu, Shiaoching Gong, Pradip Roy-Burman, Peng Lee, Zoran Culig

Open access · bronzeAbstract readReview
In one paragraph

Review in Endocrine-related cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. The mouse prostate: a basic anatomical and histological guideline.Bosnian journal of basic medical sciences · 2016
    Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Phytochemical Analysis, Antioxidant Activity, and Anticancer Potential ofInternational journal of molecular sciences · 2025
    Article
  12. Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Xinyu WuDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
Shiaoching Gong
Pradip Roy-Burman
Peng Lee
Zoran Culig
Hospital for Special Surgery · USInnsbruck Medical University · ATNew York University · USRockefeller University · USUniversity of Southern California · US

Funding

PATHOGENESIS OF HUMAN PROSTATE CARCINOMASR01CA059705 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROY-BURMAN, PRADIP · 1993 to 2012
$7.3M
Signaling Pathway Alterations in the Racial Disparity of Prostate CancerU01CA149556 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LEE, PENG, ZHANG, DAVID Y · 2011 to 2016
$1.9M
NCI NIH HHS 1U01CA149556-01NCI NIH HHS R01 CA059705NCI NIH HHS R01CA59705NCI NIH HHS U01 CA149556
6 · The paper itself

Abstract

Mouse models of prostate cancer (PCa) are critical for understanding the biology of PCa initiation, progression, and treatment modalities. Here, we summarize recent advances in PCa mouse models that led to new insights into specific gene functions in PCa. For example, the study of transgenic mice with TMPRSS2/ERG, an androgen-regulated fusion protein, revealed its role in developing PCa precursor lesions, prostate intraepithelial neoplasia; however, it is not sufficient for PCa development. Double deficiency of Pten and Smad4 leads to a high incidence of metastatic PCa. Targeted deletion of Pten in castration-resistant Nkx3-1-expressing cells results in rapid carcinoma formation after androgen-mediated regeneration, indicating that progenitor cells with luminal characteristics can play a role in initiation of PCa. Transgenic mice with activated oncogenes, growth factors, and steroid hormone receptors or inactivated tumor suppressors continue to provide insights into disease progression from initiation to metastasis. Further development of new PCa models with spatial and temporal regulation of candidate gene expression will probably enhance our understanding of the complex events that lead to PCa initiation and progression, thereby invoking novel strategies to combat this common disease in men.

Indexed as

Disease Models, AnimalProstatic NeoplasmsAnimalsBiomedical ResearchCell Line, TumorHumansMaleMiceMice, TransgenicStem CellsXenograft Model Antitumor Assaysandrogen receptoroncologyprostate

Identifiers

PMID23580590
PMCPMC3855867
OpenAlexW2007445995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.